XBiotech Inc. (XBIT) |
|
21.16 0.97 (4.8%)
|
09-20 00:23 |
|
Open: |
20.27 |
Pre. Close: |
20.19 |
|
High:
|
21.19 |
Low:
|
19.895 |
|
Volume:
|
297,142 |
Market Cap:
|
613M |
|
|
|
|
XBiotech, Inc. is a biopharmaceutical company. The company is headquartered in Austin, Texas and currently employs 58 full-time employees. The firm is engaged in discovering and developing True Human monoclonal antibodies for treating a range of different diseases. The company focuses on its lead product candidate, Xilonix (MABp1), which is derived from a natural human immune response. The firm has also developed a True Human monoclonal antibody discovery platform and manufacturing system. Xilonix is a therapeutic antibody, which specifically neutralizes interleukin-1 alpha (IL-1a). Its pipeline includes various human antibodies for treating diseases, such as cancer, vascular disease, inflammatory skin disease and diabetes. The firm has completed a Phase III study in Europe for the treatment of symptomatic colorectal cancer. The company also investigated its lead product candidate in clinical trials for other inflammatory conditions, including vascular disease, type II diabetes, acne, psoriasis, pyoderma gangrenosum (PG) and hidradenitis suppurativa (HS). |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
21.203 - 21.265 |
21.265 - 21.336 |
|
Low:
|
19.716 - 19.79 |
19.79 - 19.873 |
|
Close:
|
21.023 - 21.14 |
21.14 - 21.272 |
|
Technical analysis |
as of: 2020-09-18 4:37:14 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 24.86 One year: 29.03 |
| Support: |
Support1: 18.34  Support2: 16.52 |
| Resistance: |
Resistance1: 21.28 Resistance2: 24.86 |
| Pivot: |
19.33 |
| Moving Average: |
MA(5): 20.23 MA(20): 19.20
MA(100): 15.88 MA(250): 14.88 |
| MACD: |
MACD(12,26): 0.89 Signal(9): 0.80 |
| Stochastic oscillator: |
%K(14,3): 83.51 %D(3): 81.85 |
| RSI: |
RSI(14): 67.88 |
| 52-week: |
High: 26.40 Low: 8.18 Change(%): 104.2 |
| Average Vol(K): |
3-Month: 20781 10-Days: 19827 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.XBIT has closed above the upper band by 5.9%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 21.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Fri, 18 Sep 2020
XBiotech Inc (NASDAQ:XBIT) Short Interest Update - MarketBeat
Tue, 01 Sep 2020
Stocks To Watch: XBiotech Inc. (XBIT) Is Creating Trading Opportunities - Invest Million
Fri, 28 Aug 2020
XBiotech Inc. (XBIT) Soars 3.07% on August 28 - Equities.com
Thu, 27 Aug 2020
Austin experts weigh in on convalescent plasma after FDA authorization - Austin Business Journal
Mon, 24 Aug 2020
XBiotech, AstraZeneca rise; Churchill Downs, Gilead fall | Business - Lincoln Journal Star
Mon, 24 Aug 2020
BUZZ-U.S. STOCKS ON THE MOVE-Apple Inc, Tesla Inc, XBiotech, Onconova Therapeutics - Nasdaq
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
29 |
| Shares Float (M) |
14 |
|
% Held by Insiders
|
67.34 |
|
% Held by Institutions
|
17.45 |
|
Shares Short (K)
|
2,040 |
|
Shares Short P. Month (K)
|
1,970 |
Stock Financials |
|
EPS
|
15.240 |
|
EPS Est This Year
|
-1.290 |
|
EPS Est Next Year
|
-1.540 |
|
Book Value (p.s.)
|
11.890 |
|
Profit Margin
|
2390.03 |
|
Operating Margin
|
-99.74 |
|
Return on Assets (ttm)
|
-8.2 |
|
Return on Equity (ttm)
|
326.2 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
0.972 |
|
EBITDA (p.s.)
|
-0.891 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-81 |
|
Levered Free Cash Flow (M)
|
-24 |
Stock Valuations |
|
PE Ratio
|
1.39 |
|
PEG Ratio
|
|
|
Price to Book value
|
1.78 |
|
Price to Sales
|
21.77 |
|
Price to Cash Flow
|
-7.58 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
